Inventor · disambiguated record
Hui-Ju Chen
Also filed as: CHEN HUI-JU · CHEN HUI-JU J
17 granted patents·10 pending applications·100 citations·filing 1999–2017
90Inventor score
Top patents by PatentIndex Score
27 records- 0192US9464082B2Aryl and arylalkyl substituted pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulatorsABBVIE INC·Filed 2015·Granted Oct 11, 2016·18 cites·24 claims
- 0291US6455571B1Inhibitors of neuraminidasesABBOTT LAB·Filed 1999·Granted Sep 24, 2002·60 cites·115 claims
- 0383US8642538B2Macrocyclic hepatitis C serine protease inhibitorsKU YIYIN·Filed 2012·Granted Feb 4, 2014·8 cites·20 claims
- 0483US8420596B2Macrocyclic hepatitis C serine protease inhibitorsKU YIYIN·Filed 2009·Granted Apr 16, 2013·7 cites·20 claims
- 0573US8937041B2Macrocyclic hepatitis C serine protease inhibitorsMCDANIEL KEITH F·Filed 2011·Granted Jan 20, 2015·2 cites·18 claims
- 0672US9676797B2Anti-viral compoundsABBVIE INC·Filed 2016·Granted Jun 13, 2017·1 cites·15 claims
- 0769US6831096B2Inhibitors of neuraminidasesABBOTT LAB·Filed 2002·Granted Dec 14, 2004·3 cites·9 claims
- 0868US2014243340A1Cytochrome p450 oxidase inhibitors and uses thereofABBVIE INC·Filed 2014·Application pending·0 cites
- 0966US2008161246A1Cytochrome P450 Oxidase Inhibitors and Uses ThereofABBOTT LAB·Filed 2007·Application pending·0 cites
- 1064US2013131085A1Cytochrome p450 oxidase inhibitors and uses thereofKLEIN LARRY L·Filed 2012·Application pending·0 cites
- 1163US2012309762A1Cytochrome p450 oxidase inhibitors and uses thereofKLEIN LARRY L·Filed 2012·Application pending·0 cites
- 1261US7696226B2HIV protease inhibiting compoundsABBOTT LAB·Filed 2004·Granted Apr 13, 2010·1 cites·49 claims
- 1361US2012083490A1Cytochrome p450 oxidase inhibitors and uses thereofKLEIN LARRY L·Filed 2011·Application pending·0 cites
- 1459US8497275B2HCV protease inhibitors and uses thereofGREEN BRIAN E·Filed 2009·Granted Jul 30, 2013·0 cites·14 claims
- 1557US9309279B2Macrocyclic hepatitis C serine protease inhibitorsABBVIE INC·Filed 2014·Granted Apr 12, 2016·0 cites·17 claims
- 1656US10053474B2Anti-viral compoundsABBVIE INC·Filed 2017·Granted Aug 21, 2018·0 cites·17 claims
- 1756US2013303547A1HCV Protease Inhibitors and Uses ThereofABBVIE INC·Filed 2013·Application pending·0 cites
- 1854US8653141B2HIV protease inhibiting compoundsFLENTGE CHARLES A·Filed 2012·Granted Feb 18, 2014·0 cites·31 claims
- 1953US2005131042A1HIV protease inhibiting compoundsFiled 2003·Application pending·0 cites
- 2052US9493506B2Macrocyclic hepatitis C serine protease inhibitorsENANTA PHARM INC·Filed 2014·Granted Nov 15, 2016·0 cites·21 claims
- 2149US8193227B2HIV protease inhibiting compoundsFLENTGE CHARLES A·Filed 2004·Granted Jun 5, 2012·0 cites·19 claims
- 2248US2015119319A1Macrocyclic hepatitis c serine protease inhibitorsABBOTT LAB·Filed 2015·Application pending·0 cites
- 2341US7902203B2Anti-infective agentsABBOTT LAB·Filed 2003·Granted Mar 8, 2011·0 cites·23 claims
- 2439US2014073700A1Glycyrrhetinic acid derivatives and methods of use thereofABBVIE INC·Filed 2013·Application pending·0 cites
- 2539US2019358214A1Compositions and Methods for Treating HCV InfectionABBVIE INC·Filed 2017·Application pending·0 cites
- 2638US8748374B2Macrocyclic hepatitis C serine protease inhibitorsCHEN HUI-JU·Filed 2011·Granted Jun 10, 2014·0 cites·20 claims
- 2736US8951964B2Phenanthridine macrocyclic hepatitis C serine protease inhibitorsMCDANIEL KEITH F·Filed 2011·Granted Feb 10, 2015·0 cites·20 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →